Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Division of Preventive Oncology

Prof. Dr. Hermann Brenner(in ch.)

The Division, which was established in 2009 and led by Prof. Cornelia Ulrich until 2014, initially focused on tertiary prevention of colorectal cancer. Another major focus of research successfully established is tertiary prevention by promotion of physical activity among cancer patients. The work group Physical Activity and Cancer, headed by Prof. Karen Steindorf, has initiated multiple randomized controlled trials in this field, some of which are already successfully completed, while others are ongoing. In 2016, Prof. Karen Steindorf was appointed as head of a newly established Division of Physical Activity, Prevention and Cancer.
After Prof. Ulrich left DKFZ in 2014, Prof. Hermann Brenner, head of the DKFZ Division of Clinical Epidemiology and Aging Research, started serving as temporary head of the Division upon request. Under his leadership, a highly ambitious research agenda focusing on novel avenues of cancer screening and early detection has been launched. Furthermore, a workgroup led by Dr. Mahdi Fallah on risk adapted prevention has been set up. It focuses on targeted prevention in the high risk group of first degree relatives of cancer patients.

FUTURE OUTLOOK
The research program in the secondary prevention of cancer, focusing on enhanced screening strategies and on the detection and evaluation of novel biomarkers or biomarker signatures for early detection of cancer, will be intensified. A unique data- and liquid biobank for cancer early detection will be built up in the context of the GEKKO study (Gebt dem Krebs keine Chance: Onkocheck). Apart from intensive collaboration with multiple university clinics, parts of the program will be accomplished in close collaboration with private practices engaged in screening activities, such as gastroenterology practices that offer screening colonoscopy. This will greatly contribute to the outreach of NCT activities in the community and outpatient sector. The Division will furthermore play a key role in promoting cancer prevention research within the German Cancer Consortium, where multiple large scale epidemiological and intervention studies have been successfully initiated in collaboration with other leading cancer sites in Germany.

Contact

Prof. Dr. Hermann Brenner (in ch.)
Preventive Oncology (C120)
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 581
69120 Heidelberg
Tel: +49 6221 42 1300

E-Mail:
h.brenner@dkfz.de
secretariat.prevonc@nct-heidelberg.de

Selected Publications

  • Fallah M. et al. (2016). Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries. Leukemia, 30(2), 373-378.
  • Werner S. et al (2016). Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting. Clin Cancer Res, 22(7), 1725-1733.
  • Chen H. et al. (2015). Head-to-head comparison and evaluation of 92 plasma protein biomarkers for early detection of colorectal cancer in a true screening setting. Clin Cancer Res, 21(14), 3318-3326.
  • Brenner H. et al. (2014). Colorectal cancer. Lancet, 383(9927), 1490-1502.
to top
powered by webEdition CMS